Neuroinflammation in Alzheimer’s disease: glial crosstalk, pathological modulation, and therapeutic implications
Alzheimer’s disease (AD) remains a major therapeutic challenge despite the availability of amyloid-targeting disease-modifying therapies for selected patients with early symptomatic disease. These therapies have shown that disease modification is possi…